$CAI SEC Filings

Filed On	Filing
23 Sep 2026	Form 4: Denton John Russel, See Remarks Sold 7,500 shares ($239K)
22 Sep 2026	144
17 Sep 2026	Form 4: Brille Brian J, Director Received 400,000 shares by exercise or conversion ($976K) · Sold 400,000 shares ($12.1M)
17 Sep 2026	144
14 Sep 2026	8-K: Regulation FD Disclosure Beginning on September 14, 2026, representatives of Caris Life Sciences, Inc. (the “Company”) intend to use an investor presentation (the “Investor Presentation”) in meetings with current and potential investors at the Morgan Stanley 24t...
04 Sep 2026	Form 4: Spetzler David Baxley, President Received 1,000,000 shares by exercise or conversion ($2.44M) · Sold 478,000 shares ($11.9M) · Received 250,000 shares by exercise or conversion ($610K) · 1 more
04 Sep 2026	144
03 Sep 2026	144
24 Aug 2026	144
14 Aug 2026	Form 4: Castleman Peter M, Director Received 13,192 shares as a grant or award
14 Aug 2026	Form 4: Phillips T Danny, Director Received 13,192 shares as a grant or award
14 Aug 2026	Form 4: Minor Lloyd, Director Received 13,192 shares as a grant or award
14 Aug 2026	Form 4: Gilliam Joseph E, Director Received 13,192 shares as a grant or award
14 Aug 2026	Form 4: Fredrickson David Paul, Director Received 13,192 shares as a grant or award
14 Aug 2026	Form 4: Vacirca Jeff L, Director Received 13,192 shares as a grant or award
14 Aug 2026	Form 4: Johansen Laura I, Director Received 13,192 shares as a grant or award
14 Aug 2026	Form 4: Halbert Jon, Director Received 13,192 shares as a grant or award
12 Aug 2026	SCHEDULE 13G/A
07 Aug 2026	144
07 Aug 2026	SCHEDULE 13G/A

Comments